Literature DB >> 17462300

Breast cancer heterogeneity may explain peaks in recurrence.

Donald Berry.   

Abstract

Entities:  

Year:  2005        PMID： 17462300     DOI： 10.1016/j.ijsu.2005.10.011

Source DB:  PubMed          Journal:  Int J Surg        ISSN： 1743-9159            Impact factor:   6.071


× No keyword cloud information.
  4 in total

1.  Beyond comparing means: the usefulness of analyzing interindividual variation in gene expression for identifying genes associated with cancer development.

Authors:  Ivan P Gorlov; Jinyoung Byun; Hongya Zhao; Christopher J Logothetis; Olga Y Gorlova
Journal:  J Bioinform Comput Biol       Date:  2012-04       Impact factor: 1.122

2.  Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer.

Authors:  James J Dignam; Vanja Dukic; Stewart J Anderson; Eleftherios P Mamounas; D Lawrence Wickerham; Norman Wolmark
Journal:  Breast Cancer Res Treat       Date:  2008-10-02       Impact factor: 4.872

3.  Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations.

Authors:  Massimiliano Cocca; Davide Bedognetti; Martina La Bianca; Paolo Gasparini; Giorgia Girotto
Journal:  J Transl Med       Date:  2016-01-22       Impact factor: 5.531

4.  Patterns and predictors of first and subsequent recurrence in women with early breast cancer.

Authors:  Y M Geurts; A Witteveen; R Bretveld; P M Poortmans; G S Sonke; L J A Strobbe; S Siesling
Journal:  Breast Cancer Res Treat       Date:  2017-07-04       Impact factor: 4.872
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.